PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2084767
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2084767
Hemostatic Gel Market is estimated to be valued at USD 842.6 Mn in 2026 and is expected to reach USD 1,421.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 842.6 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.80% | 2033 Value Projection: | USD 1,421.8 Mn |
The global hemostatic gel market is a niche segment within the global advanced wound care and surgical products industry, which offers a wide range of gel-based substances that are utilized to stop or reduce the amount of bleeding from the wounded part during operations, trauma management and in emergencies. Hemostatic gel agents work by assisting in the blood clot formation, forming a barrier across the bleeding site for the fastest hemostasis.
The market consists of several formulations like gelatin-based, collagen-based, chitosan-based and synthetic polymer-based gels, depending on the particular needs. Rising number of surgical cases, increased use of minimally invasive techniques and a growing need to decrease the rate of bleeding, while also avoiding surgical complications, have boosted the market for hemostatic gels. Furthermore, ongoing research and development for better biomaterials and delivery system technologies has improved the effectiveness of these products, leading to their application in different clinical domains.
The global hemostatic gel market is driven by increasing number of surgeries, rising number of trauma cases, increasing number of minimally invasive surgeries which require hemostatic agents, aging population, increasing need for advanced wound care management techniques. Also, the market is witnessing advancement and development of highly biocompatible and rapidly acting gel formulations that are used in surgical procedures for enhancing outcomes. This further boosts the market penetration of hemostatic gels among hospitals and ambulatory surgical centers.
However, the growth of hemostatic gel market is limited by factors such as stringent regulatory requirements for product approvals, cost factor for products, lack of availability of favorable reimbursement policies in some of the countries. Nevertheless, considerable opportunities are arising from the growing utilization of hemostatic gel in dental procedures, cosmetic surgeries and ambulatory surgeries. The application of hemostatic gel in new therapeutic fields along with advancement in the field of biomaterials, nanobiotechnology and biotech-based formulation is leading to new business opportunities.